A partnership comprising TransCode Therapeutics and Quantum Leap Healthcare Collaborative has submitted an investigational ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancers, in collaboration ...
Submits IND Amendment For Planned Phase 2A Trial Of TTX-MC138 In Colorectal Cancer. TransCode Therapeutics (NASDAQ: RNAZ) announced the submission of an Investigational New Drug (“IND”) application ...
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that Behrad Derakhshan, Ph.D., Chief Operating Officer, will present at the Guggenheim Emerging ...
PTC Therapeutics, Inc. announced today that the company will host a webcast conference call to report its fourth quarter and full year 2025 financial results and provide an update on the company's ...
A Bulgarian scientist has developed a drug that halts the growth of cancer and prevents metastases from spreading to other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results